Are we getting to lipid targets in real life?

被引：19

作者：

Katsiki, Niki ^{[1
,2
]}

Mikhailidis, Dimitri P. ^{[1
]}

Athyros, Vasilis G. ^{[3
]}

Hatzitolios, Apostolos I. ^{[2
]}

Karagiannis, Asterios ^{[3
]}

Banach, Maciej ^{[4
]}

机构：

[1] UCL, Sch Med, Dept Clin Biochem Vasc Dis Prevent Clinics, London, England

[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, Sch Med, Propedeut Dept Internal Med 2, Hippokrat Hosp, GR-54006 Thessaloniki, Greece

[4] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Hypertens, Lodz, Poland

来源：

ARCHIVES OF MEDICAL SCIENCE | 2010年 / 6卷 / 05期

关键词：

CORONARY-HEART-DISEASE; CHOLESTEROL TREATMENT; CARDIOVASCULAR RISK; LOWERING THERAPY; STATIN THERAPY; TRIGLYCERIDES; MANAGEMENT; EZETIMIBE; INSIGHTS; APOLIPOPROTEINS;

D O I：

10.5114/aoms.2010.17073

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：639 / 641

页数：3

共 34 条

[1] Editorial: One Century of Triglycerides, but there is Still Lots to Learn! [J].

Anagnostopoulou, K. ;

Mikhailidis, D. P. ;

Kolovou, Genovefa .

CURRENT DRUG TARGETS, 2009, 10 (04) :299-301

[2]

Angelopoulos J, 2009, ARCH MED SCI, V5, P347

[3]

[Anonymous], OPEN CARDIOVASC MED

[4] Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study [J].

Athyros, V. G. ;

Hatzitolios, A. ;

Karagiannis, A. ;

Didangelos, T. P. ;

Iliadis, F. ;

Dolgyras, S. ;

Vosnakidis, T. ;

Vasiliadis, P. ;

Malias, I. ;

Tziomalos, K. ;

Samouilidou, M. ;

Mikhailidis, D. P. .

CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) :1931-1940

[5] Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study [J].

Athyros, V. G. ;

Karagiannis, A. ;

Hatzitolios, A. I. ;

Paletas, K. ;

Savopoulos, C. ;

Giannoglou, G. ;

Mikhailidis, D. P. .

CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) :971-980

[6] Identifying and attaining LDL-C goals: Mission accomplished? Next target: New therapeutic options to raise HDL-C levels [J].

Athyros, Vasilios G. ;

Mikhailidis, Dimitri P. ;

Kakafika, Anna I. ;

Karagiannis, Asterios ;

Hatzitolios, Apostolos ;

Tziomalos, Konstantinos ;

Ganotakis, Emmanuel S. ;

Liberopoulos, Evangelos N. ;

Elisaf, Moses .

CURRENT DRUG TARGETS, 2007, 8 (03) :483-488

[7]

Banach M, 2009, MED SCI MONITOR, V15, pMS1

[8] Can consumers self-select for appropriate use of an over-the-counter statin? The self evaluation of lovastatin to enhance cholesterol treatment study [J].

Brass, Eric P. ;

Vassil, Theodore ;

Replogle, Amy ;

Hwang, Peggy ;

Rusche, Steven ;

Shiffman, Saul ;

Levine, Jeffrey G. .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (10) :1448-1455

[9] New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines [J].

Brewer, HB .

CLINICAL CARDIOLOGY, 2003, 26 (04) :19-24

[10] Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis [J].

Briel, Matthias ;

Ferreira-Gonzalez, Ignacio ;

You, John J. ;

Karanicolas, Paul J. ;

Akl, Elie A. ;

Wu, Ping ;

Blechacz, Boris ;

Bassler, Dirk ;

Wei, Xinge ;

Sharman, Asheer ;

Whitt, Irene ;

da Silva, Suzana Alves ;

Khalid, Zahira ;

Nordmann, Alain J. ;

Zhou, Qi ;

Walter, Stephen D. ;

Vale, Noah ;

Bhatnagar, Neera ;

O'Regan, Christopher ;

Mills, Edward J. ;

Bucher, Heiner C. ;

Montori, Victor M. ;

Guyatt, Gordon H. .

BMJ-BRITISH MEDICAL JOURNAL, 2009, 338

← 1 2 3 4 →